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Abstract
Background: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatment. Thus animal
models are necessary to study the OSA metastatic spread and to validate novel therapies able to control the systemic
disease. We report the development of a syngeneic (Balb/c) murine OSA model, using a cell line derived from a spontaneous
murine tumor.
Methodology: The tumorigenic and metastatic ability of OSA cell lines were assayed after orthotopic injection in mice distal
femur. Expression profiling was carried out to characterize the parental and metastatic cell lines. Cells from metastases were
propagated and engineered to express Luciferase, in order to follow metastases in vivo.
Principal Findings: Luciferase bioluminescence allowed to monitor the primary tumor growth and revealed the appearance
of spontaneous pulmonary metastases. In vivo assays showed that metastasis is a stable property of metastatic OSA cell
lines after both propagation in culture and luciferase trasduction. When compared to parental cell line, both unmodified
and genetically marked metastatic cells, showed comparable and stable differential expression of the enpp4, pfn2 and prkcd
genes, already associated to the metastatic phenotype in human cancer.
Conclusions: This OSA animal model faithfully recapitulates some of the most important features of the human malignancy,
such as lung metastatization. Moreover, the non-invasive imaging allows monitoring the tumor progression in living mice. A
great asset of this model is the metastatic phenotype, which is a stable property, not modifiable after genetic manipulation.
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Introduction
Osteosarcoma (OSA) is the most common primary malignant
tumor of bone. OSA derives from primitive bone-forming
mesenchyme and it is characterized by the proliferating spindle
cells production of osteoid tissue or immature bone. OSA accounts
for 60% of all malignant childhood bone tumors [1]. The age
distribution is bimodal: the first major peak occurring during the
second decade of life, and the second much smaller peak being
observed in patients over 50 years-old. The distal femoral and
proximal tibial metaphyses are the most common sites for OSA.
Approximately 50% of cases are localized in the knee region [2].
OSA is a progressive and often fatal disease [3]. In absence of
adjuvant therapy, removal and treatment of the primary tumor is
successful in only 20% of the cases, while chemotherapy regiments
combined to surgery reduces relapses and metastases under 40%.
At diagnosis, approximately 80% of patients are believed to have
metastatic disease, but the current diagnostic tools allow to detect
only 8–15% of these patients [4]. In particular, many patients bear
undetectable pulmonary micrometastases. In fact, a distinct
feature of OSA is a preference for pulmonary metastases
compared with other sites. After radiological detection of lung
metastasis, 5 years survival rates are less than 30% [5]. Thus new
therapies are necessary, and the development of clinically relevant
animal models could be really helpful for this purpose.
The mouse model provides the most relevant setting to study
and molecularly dissect the process of metastasis in vivo. It is
interesting to note that metastatic spread of experimental or
spontaneous tumors is a surprisingly rare event in murine
compared to human cancer. For this reason few mouse models
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are available to study the metastatic phenotype and its progression
[6]. Several experimental assays have been developed in mice to
assess the metastatic ability of OSA cells, which can be injected in
specific anatomical sites, analyzing their ability to form tumors
and/or to metastasize via haematogenous spread [7]. Recently,
the development of a novel bioluminescent in vivo imaging system
(IVIS) allowed monitoring in real-time labeled substances or cells
in experimental animals. In cancer research this technology was
successfully used to study tumor progression and to verify efficacy
of new therapies [8,9]. IVIS has been also used to monitor viral
[10] and bacterial infections [11,12], to study transcriptional
regulation of human genes [13] and to evaluate the distribution of
drugs [14].
In this work we describe the establishment of a Luciferase-
labelled metastatic OSA model, which can be monitored in vivo.
Highly and poorly metastatic cell lines were originally established
from an OSA, spontaneously arising in a Balb/c mouse [15,16].
Metastatic cells were selected in vivo and engineered to express a
reporter gene (Luciferase). Upon orthotopic injection, i.e. into the
right distal femur of syngeneic hosts, IVIS allowed monitoring
tumor growth and metastases. IVIS assay and gene expression
showed that the metastatic OSA cells phenotype was maintained
after propagation in culture and gene marking.
Materials and Methods
OSA cell culture and characterization
Different OSA cell lines (K1–K5) were provided by Dr. J.
Schmidt [15]. Lines had been obtained from the primary culture
of a spontaneous OSA which arose in the distal femur of an 894-
day-old female Balb/c mouse [15]. Cells were grown in DMEM
(Dulbecco Modified Eagle Medium, Cambrex, Walkersville, MD)
supplemented with 10% FBS (Fetal Bovine Serum, Cambrex,
Walkersville, MD), 2 mM L-Glutamine (Cambrex, Walkersville,
MD), 10000 U.I./mL penicillin-streptomycin (Cambrex, Walk-
ersville, MD) and incubated at 37uC in a 5% CO2 water saturated
atmosphere K5L cells were obtained by a K5 metastatic lung
nodule excision, generated from K5 cell line orthotopic injection.
OSA cells were tested for alkaline phosphatase (ALP) expression
by immunohistochemistry. 36105 cells were plated in a 24
multiwell plate, after adhesion they were stained and ALP
expression was quantified using the method of scoring described
in the manifacturer’s instructions (Sigma Aldrich, St. Louis, MO).
Briefly, we evaluated the intensity of staining using fibroblast as
negative control, while our cells showed a strong intensity of stain.
Total RNA extraction and Real-time PCR
Total RNA was prepared as previously described [17]. To
determine the amount of specific RNA products of the ecto-
nucleotide pyrophosphatase/phosphodiesterase (enpp4), profilin2
(pfn2) and Protein Kinase Cd (prkcd) genes, cDNA was subjected to
quantitative PCR, using Sybr green Master MIX (Applied
Biosystem, Foster City, CA) and MyiQ single-color Real Time
PCR detection System (Biorad Inc., Hercules, CA). Each experiment
was repeated three times independently, to ensure the reproducibil-
ity of results. Primer sequences were designed using Primer Express
Software (Version 1.5). Sequences are available from the authors.
Motility and MatrigelH invasion assay
Motility and invasion assays were performed in 6.5 mm
diameter transwell chambers (Costar, Cambridge, MA). The
upper side of the porous polycarbonate membrane (8.0 mm pore
size) was coated with 10 mg/cm2 reconstituted MatrigelH base-
ment membrane (Collaborative Biomedical Products; Becton
Dickinson Labware, Waltham, MA). Cells (2.56104/well) were
seeded on the upper side of the filter and incubated in DMEM
medium and 0,5% FBS. The lower chamber was filled with
medium containing 0,5% FBS.
After 16h for motility assay or 24h for invasion assay, cells on
the upper side of the filters were mechanically removed. Cells
migrated to the lower side were fixed with 11% glutaraldehyde in
Phosphate Buffer Saline (PBS) and stained with 0,1% crystal violet
in 20% methanol. The filters were photographed and cells were
semi-quantitatively counted. MDCK cell line was used as motility
and invasiveness control in presence of Hepatocyte Growth Factor
(100 ng/ml).
Anchorage-independent cell-growth assay
Cells were suspended in 0,35% type VII low melting agarose in
DMEM (10% FBS) at 26104 cells/well, plated on a layer of 0,7%
agarose in DMEM (10% FBS) in 6-well culture plates and cultured
at 37uC with 5% CO2. After three weeks colonies .100 mm in
diameter were counted.
Vector construction
Lenti-LUC was generated by subcloning of firefly-luciferase gene
from pGL3-Control (Promega, Madison, WI) in SmaI and XbaI
sites of pCCL.sin.cPPT.polyA.CTE.eGFP.minhCMV.hPGK.del-
taNGFR.WPRE transfer vector, which represents a 3rd generation
of lentiviral vector (self-inactivating lentiviral vector) [18]. For the
amplification of plasmid, the ligation product was used to transform
TOP TEN Bacteria (Invitrogen, Carlsbad, CA). These bacteria were
selected on ampicillin-agar plate at 37uC for 16 h, then bacteria with
the interest plasmid were grown in 200 mL of LB medium (Bacto-
tryptone 10 g, bacto-yeast extract 5 g, NaCl 10 g) with ampicillin.
The plasmid DNA was extracted with GenEluteTM High Perfor-
mance Plasmid Maxiprep Kit (Sigma Aldrich, St. Louis, MO).
Lentiviral vector production
High titer lentiviral vector stock was produced in 293T cells by
calcium phosphate-mediated transient transfection of pCCL.sin.
cPPT.polyA.CTE.eGFP.minhCMV.hPGK.Luciferase.Wprep (10 mg)
and packaging vectors pMDLg/pRRE (5 mg), pRSV-REV
(2.5 mg) and pMD2.VSVG (5 mg). Supernatants were harvested
after 30 h, filtered through 0.22 mm pore size filters (Millipore,
Billerica, MA) and used directly or after concentration by
ultracentrifugation (50,0006g for 2 h). K5L cells were plating
12 h before (16105 in 35 mm diameter culture dishes) and were
transduced by the virus described above obtaining K5L-Luc.
The medium was changed 24h after infection.
Luciferase assay
The luciferase activity of K5L-Luc cells was tested by the
Luciferase Assay System purchased from Promega (Madison, WI).
As negative control we used both K5 and K5L cells. Briefly, 46105
cells were treated with lysis solution and 50 ml of cell suspension was
added to 100 ml of luciferin mix. The luciferase activity was quickly
measured by a luminometer with 10 seconds integration time.
Animal model
Female 4–5 week old Balb/c mice (purchased by Charles River
Laboratories, Calco, Milano) were housed under pathogen free
conditions with a 12 h light/12 h dark schedule, fed autoclaved
standard chow and water ad libitum.
Mice were manipulated and housed according to protocols
approved by the Turin University Bioethical Committee and the
Italian Ministry of Health.
Bioluminescent OSA Mouse Model
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For the intra-femur injections, exponentially growing K5, K5L
and K5-Luc OSA cells were harvested, counted and resuspended
in PBS to a final concentration of 107 cells/ml. The animals were
anesthetized with ketamine (80 mg/kg) and xylazine (7 mg/kg).
The knee of the Balb/c mouse was fixed beyond 90u and 16106
cells resuspended in 100 ml of PBS was injected into the distal
femur using a 25 gauge needle.
Weekly, mice were monitored for tumor size and evidence of
morbidity related to the primary tumor or pulmonary metastases.
Tumor size was quantified in two dimensions using calipers.
Tumor volume was calculated as follows: tumor volume
(mm3) =D6d2/2, where D represents the largest cross sectional
diameter (mm) of the tumor and d the cross sectional diameter
(mm) at right angles to D.
In Vivo Imaging System (IVIS)
IVIS consists of a highly sensitive, charge-coupled digital
camera with accompanying advanced computer software for
image data acquisition and analysis. This system captures photons
of light emitted by reagents or cells that have been coupled or
engineered to produce bioluminescence in the living animal [19].
The substrate luciferin was injected into the intraperitoneal cavity
at a dose of 150 mg/kg body weight (30 mg/ml luciferin),
approximately 5 minutes before imaging. Mice were anesthetized
with isoflurane/oxygen and placed on the imaging stage. Ventral
and dorsal images were collected for 30 seconds to 2 minutes
using the IVIS (Xenogen Corp., Alameda, CA). Photons emitted
from the primary tumor and lung region were quantified using
Living Image software (Xenogen Corp., Alameda, CA).
India ink assay
Pulmonary metastases were enumerated by intra-tracheal
injection of india ink (15% India Ink, 85% water, 3 drops
NH4OH/100 ml). India ink injected lungs were washed in Feket’s
solution (300 ml 70% EtOH, 30 ml 37% formaldehyde, 5 ml
glacial acetic acid) and then placed fresh Feket’s solution
overnight. White tumor nodules against a blue lung background
were counted.
Histopathological analysis
The primary tumors and the lungs were harvested at necropsy
and fixed in 10% formalin. The bone specimens were subjected to
Cal-Ex decalcifying solution overnight. The fixed samples were
then embedded in paraffin and three non-sequential serial sections
Figure 1. In vitro characterization of OSA cell lines. ALP expression in K5 (A) and K5L (B) cells was detected using cytochemical method and
analyzed by light microscopy. Both cell lines showed comparable protein expression. (Magnification 206). To assess the biological features of K5 and
K5L cells, cell motility (C) and invasiveness (D) were evaluated in transwell chambers in starving condition. Cells migrated through the porous filter
were counted after 16 h incubation (C). Cells migrated through the artificial basement membrane (MatrigelH) were counted after 24 h incubation (D).
In both panels Y-axis shows average migrated cell number (6S.D.) of triplicate wells in a representative experiment.
doi:10.1371/journal.pone.0001828.g001
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per animal were obtained. The sections were stained with
hematoxylin/eosin and analyzed for the presence of metastases
by light microscopy. The total number of metastases per lung
section was counted and averaged among the animals.
Statistical analyses
Statistical analyses were performed with the Statistical Package
for the Social Sciences (spssx/pc) software (SPSS, Chicago, IL,
USA). Continuous variables were expressed as mean and standard
deviation. Univariate analyses were performed by one way analysis
of variance. The results were considered statistically significant for
p,0.05.
Results
Characterization of the murine OSA cell lines
Continuous cell lines (K1–K5) were obtained from a spontane-
ous OSA, which arose in the distal femur of a Balb/c mouse [15].
We injected orthotopically a metastatic cell line (K5), i.e. in the
distal femur of syngeneic mice, and obtained some metastases.
One of these metastases was propagated in vitro (K5L) and further
analyzed. Propagated K5L cells were re-injected orthotopically
and found to be more tumorigenic than parental K5 cells. In fact,
after 3 weeks, 10/10 of injected mice showed tumor growth, while
tumor grew in only 6/10 animals which received the K5 parental
cell line. Since ALP expression is a marker of the osteoblast lineage
[20], we compared ALP protein expression between K5 and K5L
cell lines. The assay indicated strong ALP positivity in both cell
lines (Fig. 1 A–B).
We investigated cell motility and invasion ability of the parental
K5 and the metastasis-derived K5L cells. We used an artificial
matrix containing laminin and Collagen I (the predominant
matrix molecules in bone) and we showed that the parental and
the metastatic cells had similar ability to migrate across the
membrane (Fig 1 C–D). An anchorage-independent growth is a
sign of increased aggressiveness, thus we cultured cells in soft agar
showing that both the K5 and the K5L cells formed colonies in a
soft agar suspension within 17 days (data not shown).
As in vitro growth properties of K5 and K5L cells did not differ,
we wondered whether in vivo properties were associated to the
acquisition of specific expression profiles. To characterize these
cell lines, we performed expression profiling of these and other
clones derived from the spontaneous OSA, arose in the distal
femur of a Balb/c mouse [15] and which were reported to be
tumorigenic but not invasive in vitro and metastatic in vivo. In the
same assay, we tested other clones displaying invasiveness in vitro
and tumorigenic and metastatic phenotype in vivo [16]. This
analysis (not shown) allowed us to identify three genes, which had
the highest differential expression in the in vivo metastatic K5L cells
(enpp4, prkcd and pfn2). By means of qPCR, we demonstrated the
significantly increased expression of enpp4 (Fig. 2A, p,0.001) and
prkcd (Fig. 2B, p,0.04) and the reduced expression of pfn2 (Fig. 2C,
p,0.001) in metastatic cells. Interestingly, expression of these
three genes has been already associated to the metastatic
phenotype of human cancer cells [21–25].
Imaging tumorigenesis and metastasis in vivo using IVIS
Although the metastasis-derived cells showed slight increase
tumorigenicity, in vitro growth, motility and invasion assays showed
superimposable phenotypes. We found differential expression of
three metastasis associated genes. Thus, we wondered whether the
metastatic phenotype of the metastasis-derived K5L cells was
maintained by cells propagated in culture.
The metastatic K5L cells were engineered to stably and
constitutively express both the Green Fluorescent Protein (GFP)
and Luciferase by lentiviral-mediated gene transfer. By microscopy
GFP fluorescence allowed to verify that approximately 40% of the
cells presented viral integration. By seeding increasing amounts of
the bulk-infected cells in a multiwell plate and subjecting it to IVIS,
we determined that a Luciferase signal was detectable starting from
the highest cell dilution (50,000 cells/well) and that signal intensity
was roughly proportional to cell number (Fig. 3 A–B–C).
In order to rule out possible modifications of the neoplastic
phenotype induced by lentiviral infection, we verified that in vitro
K5L-Luc cells had migratory and invasive ability comparable to
K5 and the K5L, without showing any statistically significant
differences (Fig. 3 D–E). Moreover, we found that expression
Figure 2. Expression of the enpp4, prkcd, pfn2 genes in OSA cell
lines. The amount of enpp4, prkcd, pfn2 transcript in the K5, K5L, K5L-
Luc cell lines was measured (A,B,C respectively). The expression levels
were all compared to that of the mRNA of the K5 cells, the poor
metastatic parental cell lines. Each point shows the mean expression
variations (6S.D.) measured using mRNAs prepared from three
experiments carried out independently. The mean fold change in
expression of the target gene in each cell line versus K5 cells was
calculated using the method 22DDCT.
doi:10.1371/journal.pone.0001828.g002
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profiles of K5L-Luc cells were not modified, as also demonstrated
by selected transcript validation (Fig. 2 A–B–C).
For the in vivo experiments, we selected as marker the Luciferase
reporter protein, since bioluminescent Luciferase imaging proved
to be more sensitive than fluorescent GFP imaging. Furthermore,
the GFP signal is not sufficient to overcome tissue scattering from
more than a few millimeters’ depth [26], making it unsuitable to
monitor metastatic localization.
We determined the ability of the K5L and K5L-Luc cells to
develop spontaneous lung metastases in Balb/c mice. Experimen-
tally, 106 cells were injected into the distal femur of Balb/c mice,
and then we checked the K5L-Luc cell localization immediately
after injection using IVIS (Fig 4A). Subsequently, we weekly
checked the injected animals for Luc bioluminescence by IVIS to
monitor tumor growth and to visualize the presence of distant
metastases in the animals (Fig. 4B). At 21 days after injection,
primary tumors were macroscopically detectable in all mice of
both groups. At 38 days, we observed by IVIS the first sign of
metastasis in one animal (Fig. 4C). Numerous metastases could be
detected by IVIS during the subsequent week in every animal of
this group. At 45 days after tumor cells injection, the animals of
both groups were sacrificed for ethical reasons since their
condition worsened, and they developed serious dyspnea. It
should be noted that the X-ray analysis to detect metastases which
were visualized by IVIS. In fact, 38 days after the injection, X-rays
of animals did not show sign of lung metastatic spread (Fig. 4D),
while the new bone formation caused by the primary tumor was
clinically and radiographically evident (Table 1: OSA cell lines
tumorigenesis and metastatic ability).
The histology of the primary tumors showed solid growth with
high proliferation index, extensive osteoid matrix and bone
formation, characterized by highly cellular masses of densely
packed large mesenchymal cells (Fig 4F). The K5L-Luc cells
permeated the bone trabeculae to implement bone destruction.
Histological analysis of the pulmonary tissue showed tumor foci
characterized by high-grade proliferating tumor cells. These
metastatic cells were malignant mesenchymal cells similar to the
primary tumor cells (Fig 4E).
The lungs of the control mice injected with K5L cells were
removed and were stained with India ink to confirm the presence
of metastases macroscopically. Macroscopic surface metastases
were observed in all lungs (Fig 5A–B). Moreover, all mice were
evaluated for the presence of metastatic localization in other
organs. Macroscopically, we did not observe nodules on any other
Figure 3. K5L cells infected by lentivirus. K5L culture cells (A) infected by lentivirus, named K5L-Luc, constitutively express both
GFP (B) and Luciferase (C) protein. Notably over 40% of the cells plated were positive for GFP (B). Cells were plated in a 96 multiwell plate in
various dilutions and they showed a detectable luciferase signal using IVIS. From the top, wells were plated with 1,56105, 16105 e 56104 cells. Signal
intensity was roughly proportional to cell number (C). Transwell assays to compare the in vitro K5, K5L, K5L-Luc cells migratory and invasive ability
were performed in starving condition. Cells migrated through the porous filter were counted after 16 h incubation (D). Cells migrated through the
artificial basement membrane (MatrigelH) were counted after 24 h incubation (E). In both panels Y-axis shows average migrated cell number (6S.D.)
of triplicate wells in a representative experiment.
doi:10.1371/journal.pone.0001828.g003
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organs. Using IVIS we analyzed all animals injected with K5L-
Luc cells and we did not visualize metastases in liver or in other
abdominal organs.
The overall expression profile of the Luciferase engineered K5-
Luc cells was superimposable to that of the parental metastasis-
derived K5L cells (data not shown). Indeed the differential
expression of the three metastatic related genes was similar (Fig. 2).
Altogether these data show that metastatic ability is a property
stably retained in this model, even after propagation in culture and
gene marking.
Discussion
Before 1975, the treatment of appendicular OSA mainly
consisted of amputation without effective chemotherapy. The
introduction of adjuvant and neo-adjuvant chemotherapy led to a
significant improvement in prognosis [27]. Moreover, changes in
the surgical treatment towards limb sparing techniques instead of
amputation, increased quality of life of OSA patients [28].
At the time of diagnosis, significant prognostic factors are the
presence of metastases, followed by tumor volume and percentage
Figure 4. K5L-Luc mouse in vivo imaging and histologic evaluation of the primary tumors and pulmonary metastases. Fifteen minutes
after injection of 16106 K5L-Luc cells the signal from labeled cells was localized in the injection site of the right knee of the mouse (A). On day 21 from
inoculation, tumor growth at the injection site (right knee) was macroscopically detectable and documented using IVIS. The only source of emission is
circumscribed to the injection site (B). Thirty-eight days after K5L-Luc cells injection, a first luminous signal was evident at pulmonary level (C). X-ray
analysis (D) revealed an aggressive destructive growth pattern toward knee region with periosteal new bone formation at the site of injection (red
arrow), but did not show sign of metastatic spread to lung (yellow arrow).At 45 days histologic analysis of the K5L-Luc orthotopic primary tumor
section (F) revealed densely packed malignant mesenchymal cells consistent with osteoid formation and bone trabeculae, including invasion of
normal bone (Magnification 106). Non-sequential serial sections were taken from lungs of the injected K5L-Luc animals and section through a visible
pulmonary metastasis (E) revealed malignant mesenchymal cells proliferating in the lung parenchyma. Staining with eosin hematoxylin was
performed (Magnification 406).
doi:10.1371/journal.pone.0001828.g004
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of tumor necrosis at primary site after neo-adjuvant chemotherapy
[29]. Despite the successful surgical treatment of the primary site,
the presence of micrometastases, resistant to chemotherapeutic
regimens, is responsible for the failure of the cure. Therefore, the
study of lung metastases is needed to improve treatment outcomes
and to identify patients with the highest risk for metastatic spread.
Metastatic models of tumorigenesis in experimental animals are
rare even though they are fundamental to understand the cancer
invasive behavior. Studies of human OSA were conducted in nude
mice or otherwise immuno-compromised mice [7,30] and in some
of these cases OSA was induced by injecting human tumor cells
either intravenously or subcutaneously [20]. These mice models
might not be clinically relevant because OSA cells are not
spontaneously arisen and do not grow in the proper site.
Moreover, tumor progression and metastases development do
not mimic the human clinical course of OSA and lack
immunological response. Otherwise, the heterologous models
might bias the biology of the disease involving response to
histocompatibility antigens and/or other species specific moieties.
We focused on a mouse spontaneous OSA, which is
characterized by spontaneous pulmonary metastases after ortho-
topic implant of tumor cells [15,31]. In this orthotopic OSA model
tumor progression and metastasis development follow the human
clinical scenario. Thus we used it to study the migratory and
invasive properties of a new OSA cell line, able to form osteogenic
tumors and metastases in syngeneic Balb/c mice. We show that
the metastasis derived cells are slightly more tumorigenic but
strongly more metastatic than the parental ones. Interestingly,
gene expression analysis showed that three genes are differentially
expressed in the metastatic cells (prkcd, pfn2, enpp4). These genes
were previously correlated to cancer cell invasion and metastasis.
In particular, prkcd triggers cell migration and confers metastatic
potential to a variety of normal and tumor cells, such as breast
[21,22] and gastric cancer cells [23]. In agreement with our
results, a dramatic down regulation in the expression of pfn
isoforms has been found in invasive breast cancer cells compared
with its non tumorigenic counterparts using gene expression
profiling [30]. Furthermore, overexpression of pfn in breast cancer
cells resulted in changes in morphology and cytoskeletal
organization and caused suppression of tumorigenicity in a nude
mouse model [30]. The aberrant expression of enpp family has
been involved in cell motility and migration, angiogenesis, tumor
cell invasion and bone mineralization dysfunction but the
underlying mechanisms largely remain to be determined [31].
The K5L cell line was transduced to express luciferase using
Lentivirus vector, which integrate efficiently into the genome of
the target cells. It is known that Lentivirus vector do not transfer
any viral gene and they can be used for stable in vivo gene delivery
in non-dividing cells without affecting morphology, marker
proteins and characteristic behavior specific of the parental cells
[32]. As expected, after lentiviral infection we did not observe
changes in K5L-Luc cells biological properties compared to
parental K5L cells.
The K5L-Luc cells formed tumors locally in the injection site
and produced numerous spontaneous metastases. Interestingly, in
vivo assays and expression profiles showed that the metastatic
phenotype is a stable property acquired by cells growing in vivo,
stably maintained after in vitro propagation and not modified by
Lentiviral trasduction.
Many strategies to visualize tumor cells in animal models have
been reported [7,33,34] but to our knowledge, this is the first
report of a murine syngeneic Balb/c, spontaneous OSA model in
which OSA cells are detectable in real-time by in vivo imaging. In
fact, this approach, based on a spatio-temporal imaging analysis of
the metastatic process, does not require the sacrifice of mice at
selected time-points to evaluate tumor and metastasis growth. The
optical detection of luminescent tumor cells in vivo represents a
powerful tool to follow the tumor progression in laboratory
Table 1. OSA cell lines tumorigenesis and metastatic ability
Cell line
Animals with primary
tumor at 21 days (%)
Tumor-bearing animals with
lung mts^ at 45 days (%)
K5 60 6/10* 30 2/6u
K5L 90 9/10* 100 9/9u
K5L-Luc 100 10/10* 100 10/10u
^: metastases
*: number of animals with primary tumor/number of injected animals
u: number of animals with lung metastases/number of animals with primary
tumor
doi:10.1371/journal.pone.0001828.t001
Figure 5. Lung metastases’ macroscopic analysis. At 45 days after
tumor cells injection, the animals injected with K5L and K5L-Luc cells were
sacrificed. Macroscopic surface metastases were observed in all lungs (A).
The lungs of the mice injected with K5L cells were removed and stained
with India ink (B).Using IVIS we analyzed lungs of animals injected with
K5L-Luc cells (C). When the isolated lungs were exposed to X-ray, the latter
highlighted calcified metastasis (D, yellow arrow).
doi:10.1371/journal.pone.0001828.g005
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animals. It is a reliable system to evaluate anti-osteosarcoma
strategies, especially against post-surgical micrometastatic disease.
The IVIS use for non-invasive quantification of reporter gene
expression (luciferase) from live cells as well as from live animals is
helpful for fast screening at relatively low cost.
Finally, in human and veterinary preclinical study, considering
the high incidence of naturally occurring OSA in dogs, this mouse
model could be used as a tool, to obtain a proof of concept of the
efficacy of novel therapeutic approaches.
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